Sumitomo Pharma names Katsunori Maruta head of program management at Sumitomo Pharma AmericaPUBT·5 hours ago4506
Sumitomo Pharma Q1 FY27 net profit rises 51.7% to JPY 17 billion; revenue increases 19.9% to JPY 129.5 billionPUBT·Jul 31 at 01:36 AM4506
Poxel Publishes Its Turnover for the Second Quarter of 2026 and Announces the Postponement of the Publication of Its 2025 Financial StatementsMorningStar·Jul 30 at 02:53 PM4506
Poxel expects 2026 TWYMEEG Japan royalties to rise to 12% on Sumitomo sales forecastPUBT·Jul 30 at 02:30 PM4506
Sumitomo Pharma, Novo Nordisk’s Wegovy wins Japan approval for MASH indicationPUBT·Jun 19 at 12:15 AM4506NVO-8.78%
Japan Approves Pioneering Regenerative Medicine Products Using iPS CellsCoinLive·Mar 6 at 03:00 PM4506
